American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (986)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (940)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1255)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (311)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (62)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5172)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PRMT1-mediated methylation of DUSP4 determines megakaryocyte-erythroid lineage choice by regulating p38 signaling
    Meeting Abstract

    Su, H. R.; Tran, N. T.; Guo, H.; Luo, M.; Zhao, X. T.
    Blood (2015)

    Fulltext@MSK | Save
  • Updated efficacy and safety data from the AETHERA trial of consolidation with brentuximab vedotin after autologous stem cell transplant (ASCT) in Hodgkin lymphoma patients at high risk of relapse
    Meeting Abstract

    Sweetenham, J.; Walewski, J.; Nademanee, A. P.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A. I.; Stiff, P.; Viviani, S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Impact of busulphan exposure on transplant outcomes for patients with advanced myelodysplastic syndromes undergoing CD34 selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Tamari, R.; Proli, A.; Zheng, J. T.; Jakubowski, A. A.; Papadopoulos, E. B.; Ponce, D. M.; Devlin, S.; Sauter, C. S.; Young, J. W.; Giralt, S. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Targeting CD99 in T-cell neoplasms with monoclonal antibodies
    Meeting Abstract

    Tavakkoli, M.; Lee, D. H.; Durham, B.; Chung, S. S.; Park, C. Y.
    Blood (2015)

    Fulltext@MSK | Save
  • Safety and clinical activity of atezolizumab (anti-PDL1) in combination with obinutuzumab in patients with relapsed or refractory non-Hodgkin lymphoma
    Meeting Abstract

    Till, B. G.; Park, S. I.; Popplewell, L. L.; Goy, A.; Penuel, E.; Venstrom, J. M.; Liu, B.; Fingerle-Rowson, G.; Byon, J.; Woodard, P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • RBM15-mediated RNA splicing fine-tunes epigenetic program through interaction with SF3B1
    Meeting Abstract

    Tran, N. T.; Su, H. R.; Lu, Y. H.; Leslie, C. S.; Zhao, X. Y.
    Blood (2015)

    Fulltext@MSK | Save
  • Hypoalbuminemia is significantly associated with increased clearance time of high doses of methotrexate
    Meeting Abstract

    Reiss, S. N.; Buie, L. W.; Adel, N. G.; Goldman, D. A.; Devlin, S.; Douer, D.
    Blood (2015)

    Fulltext@MSK | Save
  • Early initiation of defibrotide in patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation improves day +100 survival
    Meeting Abstract

    Richardson, P. G.; Smith, A. R.; Triplett, B. M.; Kernan, N. A.; Grupp, S. A.; Antin, J. H.; Lehmann, L. E.; Miloslavsky, M.; Hume, R. L.; Hannah, A. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Meningeoma-1 cooperates with MLL and DOT1L to induce leukemia
    Meeting Abstract

    Riedel, S.; Haladyna, J.; Stevens, B.; Jordan, C. T.; Pollyea, D.; Armstrong, S. A.; Wei, Q.; Ernst, P.; Neff, T.; Bernt, K. M.
    Blood (2015)

    Fulltext@MSK | Save
  • Rapid achievement of MR(4.5) after switching from imatinib (IM) to nilotinib (NIL) in patients (Pts) with chronic myeloid leukemia in chronic phase (CML-CP): Preliminary results from ENESTgoal
    Meeting Abstract

    Ritchie, E. K.; Catchatourian, R.; Klisovic, R. B.; Deininger, M. W.; Erba, H. P.; Radich, J. P.; Savona, M. R.; Warsi, G.; Paley, C. S.; Dautaj, I.; more...
    Blood (2015)

    Fulltext@MSK | Save